The Centers for Disease Control and Prevention unveiled new guidelines Thursday for the treatment of latent tuberculosis infection in the U.S. with a 12-dose regimen, administered once-weekly under directly observed therapy. The current regimen requires daily drug administration over nine months, making the new treatment simpler and easier for patients. People with LTBI are infected […]
HIV
By Richard Ngethe, MBA, Data.FI As a data clerk in Kenya in 2005, my challenge was to work at rural hospitals digitizing client-level longitudinal data for […]
Tuberculosis
The publication of trial data showing a four-month treatment regimen for tuberculosis that is not resistant to first-line medicines as effective as the currently widely prescribed […]
Research & Development
By Mitchell Warren, executive director, AVAC In February 2020, just as the COVID pandemic began its rapid global spread, a major HIV vaccine trial called HVTN […]
Policy
By Karen Carvajal, M.D. Over the course of human history we have come a long way in our fight against the threat of infectious diseases and, […]